Edition:
United Kingdom

Prana Biotechnology Ltd (PRAN.OQ)

PRAN.OQ on NASDAQ Stock Exchange Capital Market

1.64USD
16 Nov 2018
Change (% chg)

$-0.02 (-1.20%)
Prev Close
$1.66
Open
$1.66
Day's High
$1.66
Day's Low
$1.60
Volume
2,288
Avg. Vol
2,751
52-wk High
$3.79
52-wk Low
$1.56

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.08 -0.009
Dec 0.12 -0.007
FY 2017 Jun '17 0.06 -0.007
Dec 0.07 -0.007
FY 2016 Jun '16 0.07 -0.009
Dec 0.08 -0.005
 
*Note: Units in Millions ofAustralian Dollars
**Note: Units in Australian Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Jun-18 1 2.10 2.10 2.10 --
Earnings (per share)
Quarter Ending Jun-18 1 -0.36 -0.36 -0.36 --
Year Ending Jun-18 1 -0.80 -0.80 -0.80 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.95 33.59
P/E High - Last 5 Yrs. -- 302.50 45.05
P/E Low - Last 5 Yrs. -- 83.52 24.37
Beta -0.12 0.93 0.91
Price to Sales (TTM) 241.96 119.82 5.69
Price to Book (MRQ) 0.21 14.57 5.11
Price to Tangible Book (MRQ) 1.35 13.73 6.54
Price to Cash Flow (TTM) -- 65.58 23.52
% Owned Institutions 1.78 13.48 1.86

Dividends

  Company industry sector
Dividend Yield -- 0.41 1.48
Dividend Yield - 5 Year Avg -- 0.33 1.50
Dividend 5 Year Growth Rate -- 2.78 5.08
Payout Ratio(TTM) -- 25.33 43.86

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -8.91 378.87 7.42
Sales (TTM) vs TTM 1 Yr. Ago -7.20 96.15 5.86
Sales - 5 Yr. Growth Rate -6.64 28.75 10.16
EPS (MRQ) vs Qtr. 1 Yr. Ago 20.19 28.44 21.18
EPS (TTM) vs TTM 1 Yr. Ago -40.96 -- --
EPS - 5 Yr. Growth Rate -- 32.55 10.63
Capital Spending - 5 Yr. Growth Rate 0.85 35.82 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.26
Current Ratio (MRQ) 15.88 5.36 3.09
LT Debt to Equity (MRQ) 0.00 35.97 11.53
Total Debt to Equity (MRQ) 0.00 37.79 15.71
Interest Coverage (TTM) -- -88.98 32.23

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.10 54.07
Gross Margin - 5 Yr. Avg. -- 48.20 51.84
EBITD Margin (TTM) -7,465.22 -- --
EBITD - 5 Yr. Avg -7,529.32 -546.18 11.80
Operating Margin (TTM) -7,481.33 -786.11 4.85
Operating Margin - 5 Yr. Avg. -7,541.87 -566.82 7.45
Pre-Tax Margin (TTM) -5,696.87 -750.03 5.82
Pre-Tax Margin - 5 Yr. Avg. -4,373.62 -572.10 7.86
Net Profit Margin (TTM) -5,696.87 -750.97 2.08
Net Profit Margin - 5 Yr. Avg. -4,373.62 -574.77 4.10
Effective Tax Rate (TTM) -- 25.06 23.39
Effective Tax Rate - 5 Yr. Avg. -- 20.12 24.13

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,538,980 905,691,028
Net Income/Employee (TTM) -- 818,613 107,333,733
Receivable Turnover (TTM) 0.03 19.58 5.95
Inventory Turnover (TTM) -- 2.79 3.63
Asset Turnover (TTM) 0.00 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -25.56 -2.12 11.52
Return on Assets - 5 Yr. Avg. -28.07 2.36 12.71
Return on Investment (TTM) -27.40 -0.80 15.05
Return on Investment - 5 Yr. Avg. -30.90 1.12 16.50
Return on Equity (TTM) -27.40 -0.14 16.62
Return on Equity - 5 Yr. Avg. -30.90 1.57 17.61
  1 Year 3 Year 5 Year
Sales % -7.19 -28.60 -6.64
EPS (TTM) % 2.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Prana Biotechnology Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 3.46%
# of Holders: 14
Total Shares Held: 308,180
3 Mo. Net Change: -32,180
# New Positions: 1
# Closed Positions: 2
# Increased Positions: 4
# Reduced Positions: 5
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.